RESTON, Va., June 22 /PRNewswire-FirstCall/ -- PRA International , a leading global clinical research organization, this week introduced Flex DMS(TM), an advanced data management system for clinical studies that combines electronic data capture and paper data entry in one easy-to-use system. The new technology was on display at the Drug Information Association's (DIA) annual meeting this week in Philadelphia.
"While EDC is rapidly gaining acceptance among the medical investigator community, there is still a need to manage paper reporting in as an efficient manner as possible, which led us to Flex DMS," said Greg Johnson, Vice President, Data Management at PRA. "We started with best-of-breed technology from DataLabs Clinical(TM) and integrated it with PRA's quality and process management systems to ensure maximum speed, efficiency and accuracy."
Available on a limited basis until now, PRA's Flex DMS was honored this week as a recipient of Microsoft's Pharmaceutical and Life Science Technology Innovation Award in the Clinical Development category. Currently, approximately 20 studies are in various stages of development within Flex DMS.
"DataLabs congratulates PRA International for winning this prestigious award from Microsoft," said Jim Langford, President of DataLabs. "PRA has been a visionary leader in providing added value to their clients by integrating new technology, like the hybrid capabilities of DataLabs Clinical, into their existing processes and systems. We are proud that our products could be the basis of the advanced functionality and value that Flex DMS provides."
While Flex DMS is a new platform, PRA's data management group has extensive experience in EDC having completed 52 projects involving 22,000 patients on a variety of software since 2000. The company operates on a common technology platform at all of its data management centers, located in: Lenexa, Kansas; Victoria, British Columbia; and Swansea, Wales. A fourth facility in Pune, India, is scheduled to be fully operational in the fourth quarter.
"In trials where EDC is used exclusively, traditional study timelines can often be cut in half, if not more," said Johnson. "With Flex DMS we are capturing some of that efficiency even with studies that mix EDC and PDE, enabling us to deliver more timely and accurate results to sponsors. In the near future, we will provide clients with real time access study data as well."
For more information about PRA's data management services, contact Greg Johnson at 703.464.6377 or your PRA sales representative.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements that are subject to risks and uncertainties relating to PRA International's future financial and business performance, as well as any other predictive statements dependent upon future events or conditions, or that include words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "may," "will," "estimate" or similar expressions of futurity. You should not place undue reliance on any forward-looking statements, which represent the Company's statements only as of the date of this news release and are not intended to give any assurance as to actual future events. Factors that might cause future events to differ include: the success of the launch of Flex DMS platform as well as the introduction of the integrated web portal and the value of those services to our clients; our ability to attract and retain qualified personnel; our ability to continue providing our services effectively, including the quality or accuracy of the data or reports provided and our ability to meet agreed upon schedules; the ability and willingness of our clients to continue to spend on research and development at rates comparable to or greater than historical levels; trends or events affecting the CRO industry and the demand for CRO services; government regulation, including regulatory standards applicable to CRO services; evolving industry standards; and technological changes. Events relating to PRA International could differ materially from those anticipated in these forward-looking statements and general business and economic conditions. Although these statements are based upon assumptions the Company believes to be reasonable based upon available information, they are subject to the foregoing risks and uncertainties as well as those described more fully in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of our annual report on Form 10-K. This document can be accessed in the SEC's EDGAR database found at http://www.sec.gov . Please note that PRA International assumes no obligation to update any of the forward-looking statements in this release, except as required by applicable securities laws.
About PRA International
PRA International is one of the world's leading global clinical development organizations, with over 2,400 employees working from offices in North America, Europe, South America, Africa, Australia, and Asia. PRA, an ISO 9001:2000 registered company, delivers services to its clients through a unique approach called Project Assurance(R), which represents the Company's commitment to reliable service delivery, program-level therapeutic expertise, easy, global access to knowledge, and involved senior management.
To learn more about PRA International, please visit http://www.prainternational.com or call our World Headquarters at +1 (703) 464-6300.
PRA InternationalCONTACT: John Lewis, Director-Marketing and Public Relations of PRAInternational, +1-703-464-6338, lewisjohn@praintl.com
Web site: http://www.prainternational.com/
